Adding medical cannabis to fibromyalgia treatment improved sleep and reduced other pain medications
In 102 fibromyalgia patients who added medical cannabis to their existing pain treatment, 44% showed significant sleep improvement, 33% had meaningful overall symptom improvement, and 47% reduced or stopped other pain medications over 6 months.
Quick Facts
What This Study Found
Medical cannabis most consistently improved sleep quality (44% of patients) and overall fibromyalgia impact (33%). Half of patients showed moderate improvement in anxiety and depression. Nearly half reduced or stopped concomitant analgesic treatment. Lower BMI correlated with better outcomes.
Key Numbers
102 patients enrolled. 64% retention at 6 months. 44% improved sleep (PSQI). 33% improved overall (FIQR). 50% moderate anxiety/depression improvement. 47% reduced or stopped other analgesics. BMI correlated with outcomes (p=0.017).
How They Did This
Prospective observational study of 102 consecutive fibromyalgia patients with VAS pain scores of 4 or higher despite existing treatment. Patients received oil-diluted cannabis extracts (Bedrocan: 22% THC, <1% CBD; or Bediol: 6.3% THC, 8% CBD) for 6 months.
Why This Research Matters
Fibromyalgia is difficult to treat, and many patients have inadequate pain relief. The finding that medical cannabis allowed nearly half to reduce other medications suggests it may not just add benefit but could simplify treatment regimens.
The Bigger Picture
The 64% retention rate and medication reduction data suggest medical cannabis provided enough benefit for most patients to continue, though about one-third experienced mild adverse events.
What This Study Doesn't Tell Us
No control group or blinding, so placebo effects cannot be ruled out. Self-selected patient population. Two different cannabis formulations were used, making it difficult to determine which is more effective.
Questions This Raises
- ?Which cannabis formulation (high-THC vs. balanced THC:CBD) works better for fibromyalgia?
- ?Why did lower BMI predict better outcomes?
- ?Would a controlled trial confirm these observational findings?
Trust & Context
- Key Stat:
- 47% reduced or stopped other pain medications
- Evidence Grade:
- Moderate: prospective design with 102 patients, though limited by lack of control group and blinding.
- Study Age:
- Published in 2020 in Clinical and Experimental Rheumatology.
- Original Title:
- Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.
- Published In:
- Clinical and experimental rheumatology, 38 Suppl 123(1), 53-59 (2020)
- Authors:
- Giorgi, Valeria(2), Bongiovanni, Sara, Atzeni, Fabiola, Marotto, Daniela, Salaffi, Fausto, Sarzi-Puttini, Piercarlo
- Database ID:
- RTHC-02574
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
Did cannabis replace other pain medications?
In 47% of patients, concomitant analgesic treatment was either reduced or stopped entirely during the 6-month study period, suggesting medical cannabis provided sufficient relief to replace some existing treatments.
What was the most improved symptom?
Sleep quality showed the most consistent improvement, with 44% of patients showing significant gains. This aligns with other studies suggesting cannabis may be particularly helpful for sleep-related symptoms in chronic pain conditions.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02574APA
Giorgi, Valeria; Bongiovanni, Sara; Atzeni, Fabiola; Marotto, Daniela; Salaffi, Fausto; Sarzi-Puttini, Piercarlo. (2020). Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.. Clinical and experimental rheumatology, 38 Suppl 123(1), 53-59.
MLA
Giorgi, Valeria, et al. "Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study.." Clinical and experimental rheumatology, 2020.
RethinkTHC
RethinkTHC Research Database. "Adding medical cannabis to standard analgesic treatment for ..." RTHC-02574. Retrieved from https://rethinkthc.com/research/giorgi-2020-adding-medical-cannabis-to
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.